Literature DB >> 6994584

Intracytoplasmic immunoglobulin-binding lymphoid cells (IgGLC) of the cerebrospinal fluid in multiple sclerosis and other neurological disorders.

J M Mussini, J J Hauw, N Delasnerie, E Schuller, R Escourolle.   

Abstract

A direct immunofluorescence study was performed on cerbro-spinal fluid (CSF) cells of 24 patients with multiple sclerosis (MS) and 26 control patients with other neurological disorders. A significant increase (p less than 0.01) of the percentage of lymphoid cells with intracytoplasmic IgG (IgGLC) was found in a group of 20 IgG tested MS cases as compared to a control group of 22 IgG tested patients. However, the statistical significance was lost when the same MS group was compared to a group of 10 neurological diseases with supposed immunopathological mechanisms. An increase of the percentage of the IgA-containing cells was also found in some cases of MS. A good relationship appeared between the increase of IgGLC cells and the presumed intrathecal secretion of immunoglobulins as assessed on the protein composition of the CSF. This technique might be of some value in the diagnosis of MS.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6994584

Source DB:  PubMed          Journal:  Ann Immunol (Paris)        ISSN: 0300-4910


  3 in total

1.  Class differentiation of immunoglobulin-containing cerebrospinal fluid cells in inflammatory diseases of the central nervous system.

Authors:  P Rieckmann; T Weber; K Felgenhauer
Journal:  Klin Wochenschr       Date:  1990-01-04

2.  Immunofluorescence studies of intra cytoplasmic immunoglobulin binding lymphoid cells (CILC) in the central nervous system. Report of 32 cases including 19 multiple sclerosis.

Authors:  J M Mussini; J J Hauw; R Escourolle
Journal:  Acta Neuropathol       Date:  1977-11-28       Impact factor: 17.088

3.  High prevalence of intrathecal IgA synthesis in multiple sclerosis patients.

Authors:  Úrsula Muñoz; Cristina Sebal; Esther Escudero; Maria Isabel García Sánchez; Elena Urcelay; Asier Jayo; Rafael Arroyo; Maria A García-Martínez; Roberto Álvarez-Lafuente; María C Sádaba
Journal:  Sci Rep       Date:  2022-03-11       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.